AMN Healthcare Services Inc: Form 10-K for the period ended Dec 31, 2018
Filed with the SEC on Feb 21, 2019 and accepted by EDGAR at Feb 20, 2019, 18:37 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2018-10-01 to 2018-12-31 | $528.6m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 12 months2018-01-01 to 2018-12-31 | $2.14bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2018-01-01 to 2018-12-31 | $1.44bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months2018-10-01 to 2018-12-31 | $172.5m | us-gaap:GrossProfit |
| Gross profit | 12 months2018-01-01 to 2018-12-31 | $696.4m | us-gaap:GrossProfit |
| Selling, general and administrative | 12 months2018-01-01 to 2018-12-31 | $452.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2018-01-01 to 2018-12-31 | $202.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2018-01-01 to 2018-12-31 | $16.1m | us-gaap:InterestExpense |
| Income tax | 12 months2018-01-01 to 2018-12-31 | $44.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2018-10-01 to 2018-12-31 | $35.6m | us-gaap:NetIncomeLoss |
| Net income | 12 months2018-01-01 to 2018-12-31 | $141.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2018-10-01 to 2018-12-31 | $0.74 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2018-01-01 to 2018-12-31 | $2.91 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2018-10-01 to 2018-12-31 | $0.76 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2018-01-01 to 2018-12-31 | $2.99 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2018-01-01 to 2018-12-31 | 48,668,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2018-01-01 to 2018-12-31 | $227.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2018-01-01 to 2018-12-31 | $35.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months2018-01-01 to 2018-12-31 | $67.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2018-12-31 | $13.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-12-31 | $482.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2018-12-31 | $1.49bn | us-gaap:Assets |
| Current liabilities | At period end2018-12-31 | $307.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2018-12-31 | $853.7m | us-gaap:Liabilities |
| Long-term debt | At period end2018-12-31 | $440.6m | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2018-12-31 | $639.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001142750-19-000008. Last ingested by Listed: Nov 5, 2026, 17:59 ET. Listed shows no prices and gives no investment advice.